🇺🇸 FDA
Patent

US 7960356

Oligodeoxynucleotide and its use to induce an immune response

granted A61KA61K2039/55561A61K31/7088

Quick answer

US patent 7960356 (Oligodeoxynucleotide and its use to induce an immune response) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K2039/55561, A61K31/7088, A61K39/008, A61K39/39